CITIUS ONCOLOGY, INC. (CTOR) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2025-12-22

CITIUS ONCOLOGY, INC. (CTOR) — no SEC Form 4 insider filings recorded in the last 90 days. 5 Form 8-K material event filings were reported by CTOR in the last 90 days. InsiderAlpha tracks every CTOR SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About CITIUS ONCOLOGY, INC. (CTOR)

SEC CIK	0001851484

90-Day SEC Filing Activity

Form 8-K filings (90d)	5
Latest Form 4 filing	2025-12-22

Recent CTOR Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2025-09-19	HOLUBIAK MYRON Z	Secretary	A — Grant or award	850.0K	$0.00	—	SEC
2025-09-19	MCGRATH DENNIS M	Director	A — Grant or award	300.0K	$0.00	—	SEC
2025-09-19	HOLUBIAK MYRON Z	Secretary	A — Grant or award	100.0K	$0.00	—	SEC
2025-09-19	Mazur Leonard L	Chief Executive Officer	A — Grant or award	1.70M	$0.00	—	SEC
2025-09-19	Mayersohn Joel David	Director	A — Grant or award	300.0K	$0.00	—	SEC
2025-09-19	Dutia Suren G	Director	A — Grant or award	300.0K	$0.00	—	SEC
2025-09-19	Webb Carol	Director	A — Grant or award	300.0K	$0.00	—	SEC
2025-09-19	Holuka Eugene Myron	Director	A — Grant or award	300.0K	$0.00	—	SEC
2025-09-19	Czuczman Myron	Chief Medical Officer	A — Grant or award	825.0K	$0.00	—	SEC
2025-09-19	Smith Robert Joseph	Director	A — Grant or award	300.0K	$0.00	—	SEC
2025-09-19	Bartushak Jaime	Chief Financial Officer	A — Grant or award	825.0K	$0.00	—	SEC
2025-09-19	Holuka Eugene Myron	Director	A — Grant or award	300.0K	$0.00	—	SEC
2025-09-19	HOLUBIAK MYRON Z	Secretary	A — Grant or award	850.0K	$0.00	—	SEC
2025-09-19	Mayersohn Joel David	Director	A — Grant or award	300.0K	$0.00	—	SEC
2025-09-19	Smith Robert Joseph	Director	A — Grant or award	300.0K	$0.00	—	SEC

All transactions sourced from SEC EDGAR Form 4 filings for CITIUS ONCOLOGY, INC. (CTOR). Updated in real time as new filings are submitted to the SEC.

Recent CTOR Form 8-K Material Events

2026-06-01 — Item 8.01, 9.01 [SEC]
2026-05-15 — Item 2.02, 9.01 [SEC]
2026-05-06 — Item 1.01, 2.03, 3.02, 8.01, 9.01 [SEC]
2026-04-29 — Item 8.01, 9.01 [SEC]
2026-04-28 — Item 3.01 [SEC]

Recent Insider Filings

2025-12-22 — Webb Carol (Director)
2025-12-22 — HOLUBIAK MYRON Z (Secretary)
2025-12-22 — Czuczman Myron (Chief Medical Officer)
2025-12-22 — Bartushak Jaime (Chief Financial Officer)
2025-12-22 — Mazur Leonard L (Chief Executive Officer)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in CTOR insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

CTOR Insider Trading — FAQ

What is the latest insider trade for CTOR?: CITIUS ONCOLOGY, INC. (CTOR) had 0 insider filings in the last 90 days, with the most recent on 2025-12-22. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying CTOR stock?: 0 insider purchases of CTOR were filed in the last 90 days.
How many insiders are selling CTOR stock?: 0 insider sales of CTOR were filed in the last 90 days.
Where can I see CTOR SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every CTOR SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live CTOR dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.